Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.

Cerqueira, Brenda Brenner S; Lasham, Annette; Shelling, Andrew N; Al-Kassas, Raida

Cerqueira, Brenda Brenner S; Lasham, Annette; Shelling, Andrew N; Al-Kassas, Raida.

Afiliación

Cerqueira BBS; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Lasham A; Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Shelling AN; Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Al-Kassas R; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: r.al-kassas@auckland.ac.nz.

Mater Sci Eng C Mater Biol Appl ; 76: 593-600, 2017 Jul 01.

Article en En | MEDLINE | ID: mdl-28482569

Asunto(s)

Nanopartículas; Línea Celular Tumoral; Portadores de Fármacos; Humanos; Ácido Hialurónico; Ácido Láctico; Paclitaxel; Ácido Poliglicólico; Copolímero de Ácido Poliláctico-Ácido Poliglicólico; Neoplasias de la Mama Triple Negativas

Palabras clave

Cytotoxicity; Degradation studies; Functionalized nanoparticles; Hyaluronic acid; PLGA nanoparticles; Paclitaxel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas Límite: Humans Idioma: En Revista: Mater Sci Eng C Mater Biol Appl Año: 2017 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google